ClinicalTrials.gg
RecruitingNCT07481188Updated Mar 31, 2026

Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery

An observational study in Hip Fracture, Proximal Femur Fracture and Frailty, sponsored by Trakya University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-03-31.

Primary conditionProximal Femoral FracturesRegistry: Hip FracturesReclassifiedWhy we changed it
Registry
Hip Fractures — the first condition term the registry derived for this study.
ClinicalTrials.gg
Proximal Femoral Fractures
Why
  1. The study's listed conditions name Proximal Femoral Fractures, a narrower term within Hip Fractures.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Trakya University · Observational

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
60 Years and older
Sex
All
01

Study summary

Hip fractures are serious injuries that occur mostly in older adults. Many people experience health problems or may die in the months after surgery. Doctors try to identify patients who have a higher risk of poor outcomes as early as possible.

Doctors often use the Nottingham Hip Fracture Score (NHFS) to estimate the risk of death after hip fracture surgery. This score uses information such as age and other health conditions. However, it does not fully reflect how physically vulnerable a person may be.

Another important concept is frailty. Frailty describes how strong or weak a person's overall health and physical reserve are. In this study, frailty will be measured using the Clinical Frailty Scale (CFS). This scale evaluates a person's level of independence and physical function before the fracture.

The purpose of this study is to determine whether measuring frailty can improve the prediction of death after hip fracture surgery.

Older adults with hip fractures who undergo surgery will be invited to participate in the study. Researchers plan to include about 200 participants or all eligible patients enrolled within one year, whichever occurs first. Health information that is already collected during routine hospital care will be recorded. Frailty will be assessed when participants are admitted to the hospital.

Participants will be followed for 30 days and 90 days after surgery to determine survival status. Researchers will review hospital records and may contact participants or their relatives by phone if needed.

The results of this study may help doctors better identify patients at higher risk and improve care planning after hip fracture surgery.

Read the detailed description

Hip fractures in older adults are associated with substantial morbidity, loss of independence, and high early mortality. Identifying patients at increased risk of poor outcomes is therefore an important part of perioperative care and treatment planning. Several clinical tools have been developed to estimate short-term mortality following hip fracture surgery. Among these, the Nottingham Hip Fracture Score (NHFS) is widely used and has been validated in multiple patient cohorts.

The NHFS is calculated using routinely available clinical variables such as age, comorbid conditions, and laboratory values. Although this score performs reasonably well in predicting short-term mortality, it mainly reflects comorbidity burden and demographic factors. It does not directly measure the patient's physiological reserve or overall vulnerability to stress.

Frailty has gained increasing attention as an important determinant of surgical outcomes in older adults. Frailty represents a state of reduced physiological reserve that limits the ability to recover from acute health events such as trauma or surgery. The Clinical Frailty Scale (CFS) is a practical bedside tool that classifies frailty based on functional status and the level of independence prior to illness or injury. Because it can be applied quickly in routine clinical settings, it has been used in various studies evaluating outcomes in geriatric populations.

Despite growing interest in frailty assessment, its added value when combined with established hip fracture risk scores remains uncertain. In particular, there is limited prospective evidence examining whether frailty assessment improves mortality prediction beyond existing tools such as the NHFS.

This prospective observational cohort study will collect standardized clinical data from older adults undergoing surgical treatment for proximal femoral fractures. Frailty will be assessed at hospital admission using the Clinical Frailty Scale based on the participant's functional status before the fracture. The Nottingham Hip Fracture Score will be calculated from routinely recorded clinical variables.

The analysis will examine the relationship between NHFS, frailty status, and short-term mortality following surgery. Predictive models including NHFS alone will be compared with models that incorporate both NHFS and frailty status in order to determine whether frailty provides additional prognostic information.

Understanding whether frailty assessment improves risk prediction may help clinicians identify vulnerable patients earlier and support more individualized perioperative management in older adults with hip fractures.

02

Conditions studied

  • Hip Fracture
  • Proximal Femur Fracture
  • Frailty

Browse trials for

Keywords

  • Hip fracture
  • Proximal femur fracture
  • Frailty
  • Geriatric fracture
  • Mortality prediction
03

In context

Proximal Femoral Fractures Reclassified

36 studies on the registry are indexed under Proximal Femoral Fractures; 6 are open to participants now.

This study's planned enrollment of 200 is above the median of 140 across 13 observational studies indexed under Proximal Femoral Fractures.

Browse Proximal Femoral Fractures studies →

Lead sponsor

Trakya University is the lead sponsor of 155 studies on the registry; 15 are open to participants now.

Compared within Proximal Femoral Fractures, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Hip Fractures. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Older adults admitted with proximal femoral fractures who undergo surgical treatment at Trakya University Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 60 years or older
  • Admission for acute proximal femoral fracture (femoral neck, intertrochanteric, or subtrochanteric fracture)
  • Surgical treatment for hip fracture
  • Ability to obtain clinical data required for NHFS and frailty assessment

Exclusion criteria

Exclusion Criteria:

  • Pathological fractures
  • Periprosthetic fractures
  • Hip fractures resulting from high-energy trauma or polytrauma
  • Non-operative treatment
  • Second hip fracture occurring in the same patient during the study period
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Hip Fracture Surgery Cohort

    Older adults aged 60 years or older who undergo surgical treatment for proximal femoral fractures. Frailty will be assessed using the Clinical Frailty Scale and mortality outcomes will be evaluated at 30 and 90 days after surgery.

    Other: No Intervention: Observational Cohort

Interventions

  • OtherNo Intervention: Observational Cohort

    no intervention

06

What researchers measure

Primary outcomes

  1. 90 Day All Cause Mortality

    All cause mortality occurring within 90 days after hip fracture surgery.

    Time frame: 90 days after surgery

Secondary outcomes

  1. 30 Day All Cause Mortality

    All cause mortality occurring within 30 days after hip fracture surgery.

    Time frame: 30 days after surgery

  2. Postoperative complications

    Time frame: 90 days after surgery

  3. Length of hospital stay

    Time frame: From hospital admission to hospital discharge (up to 30 days)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Maxwell MJ, Moran CG, Moppett IK. Development and validation of a preoperative scoring system to predict 30 day mortality in patients undergoing hip fracture surgery. Br J Anaesth. 2008 Oct;101(4):511-7. doi: 10.1093/bja/aen236. Epub 2008 Aug 21. PubMed 18723517 ↗
  • Narula S, Lawless A, D'Alessandro P, Jones CW, Yates P, Seymour H. Clinical Frailty Scale is a good predictor of mortality after proximal femur fracture: A cohort study of 30-day and one-year mortality. Bone Jt Open. 2020 Aug 1;1(8):443-449. doi: 10.1302/2633-1462.18.BJO-2020-0089.R1. eCollection 2020 Aug. PubMed 33215137 ↗
  • Kennedy MJ, Penfold RS, Donaldson L, Hall AJ, Davison MJ, MacLullich AMJ, Walmsley P, Clement ND, Clarke JV. The Clinical Frailty Scale is a valid and independent predictor of one-year survival in patients sustaining a hip fracture : scottish Hip Fracture Audit data from 8,092 patients. Bone Jt Open. 2025 Dec 4;6(12):1550-1558. doi: 10.1302/2633-1462.612.BJO-2025-0198.R1. PubMed 41338245 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07481188
Lead sponsor
Trakya University
Responsible party
Eşref SELÇUK (Assistant Professor, Trakya University) — Principal investigator
First posted
Mar 18, 2026
Start date
Mar 15, 2026
Primary completion
Mar 15, 2027 (estimated)
Completion
Mar 15, 2027 (estimated)
Last update
Mar 31, 2026

Study contacts

Eşref SELÇUK Asst Prof, MD
Contact
trkesref@hotmail.com
+905356319974

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion